FDA Approves Lirafugratinib for Previously Treated, Unresectable, Locally Advanced or Metastatic Cholangiocarcinoma
FDA Approves Lirafugratinib for Previously Treated, Unresectable, Locally Advanced or Metastatic Cholangiocarcinoma ascopost.com
Regulatory Approvals
Treatment invented at Nationwide Children’s for kid-killing disease gets FDA approval
Treatment invented at Nationwide Children’s for kid-killing disease gets FDA approval The Business Journals
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension
ANI Pharmaceuticals Announces the FDA Approval of Everolimus Tablets for Oral Suspension globenewswire.com
FDA Approves Bravnetsa, an Equivalent to Lutathera, for GEP-NETs
FDA Approves Bravnetsa, an Equivalent to Lutathera, for GEP-NETs Cure Today
Cordis wins FDA approval for sirolimus-eluting balloon
Cordis wins FDA approval for sirolimus-eluting balloon MedTech Dive